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Activation of the protooncogene Wnt-1 by insertion of the mouse mammary tumor virus (MMTV) is known to cause
mammary tumors in mice. Wnt-1 expression in mammary glands has been postulated to confer direct local growth
stimulation of mammary epithelial cells leading to their acquisition of a preneoplastic state. Wnt-1 expression also induces
morphological alterations in cultured normal mammary cells. However, it has not been determined whether or not trans-
formed mammary cells require continuous Wnt-1 expression for their ability to form tumors in vivo. To address this question,
we constructed antisense and sense Wnt-1 expression vectors containing a synthetic promoter composed of five high-affinity
glucocorticoid response elements (GRE5). This promoter is at least 50-fold more inducible by dexamethasone than the
promoter contained in the long terminal repeats of MMTV. The vectors were introduced into a mouse mammary tumor cell
line (R/Sa-MT) that expresses high levels of endogenous Wnt-1 mRNA and forms rapidly growing tumors when transplanted
into syngeneic hosts. Of the 12 stably transfected cell lines established (9 with antisense and 3 with sense constructs), 2
antisense cell lines (R/Sa-MT/antisense) and 1 sense cell line (R/Sa-MT/sense) were examined for inducibility by dexameth-
asone of antisense and sense Wnt-1 RNAs, changes in endogenous Wnt-1 RNA expression, and changes in cell morphology.
The growth patterns of the cells in vitro and in vivo were also examined. Our results show that (1) the levels of the expression
of endogenous Wnt-1 mRNA and protein were reduced significantly (.80%) in those cells (R/Sa-MT/antisense) that
expressed antisense Wnt-1 RNA at high levels following exposure to dexamethasone, compared to the R/Sa-MT/sense and
R/Sa-MT control cells and (2) transplantation of the R/Sa-MT/antisense cells produced smaller tumors (.0.2 cm in 16 weeks)
compared to the tumors (.2.0 cm in 8 weeks) that were produced by the R/Sa-MT/sense and R/Sa-MT cells. We therefore
suggest that Wnt-1 expression is required not only for the transformation of normal mammary cells into tumor cells, but also
for the maintenance of their tumorigenicity. © 1999 Academic PressKey Words: Wnt-1 protooncogene; antisense RNA; cell morphology; mouse mammary tumor; tumor growth.
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eINTRODUCTION
Insertional mutations caused by the mouse mammary
umor virus (MMTV) in a number of protooncogenes,
uch as int-1/Wnt-1 (Nusse and Varmus, 1982; Nusse et
l., 1984), int-2/Fgf-3 (Peters et al., 1983; Dickson et al.,
984; Shackleford et al., 1993a), and int-3 (Gallahan and
allahan, 1987; Sarkar et al., 1994), are thought to be
nvolved in the development of spontaneous mammary
umors in mice. To address the question of how MMTV
ctivated int genes contribute to the transformation of
ormal mammary epithelial cells into cancer cells, a
umber of structural and functional studies of the Wnt-1
ene have been carried out. Since its identification in
984, Wnt-1 has been demonstrated to be a member of a
arge group of developmentally regulated genes, includ-
ng the segment polarity gene wingless of Drosophila (for
eview see Nusse and Varmus, 1992). In fact, the Dro-
ophila gene, like mouse Wnt-1, is capable of causing
ransformation and mitogenesis of mouse mammaryi1 To whom reprint requests should be addressed.
042-6822/99 $30.00
opyright © 1999 by Academic Press
ll rights of reproduction in any form reserved.
138ells and of converting them to a tumorigenic phenotype
Ramakrishna and Brown, 1993). Wnt-1 also normally
unctions in the embryonic central nervous system
Nusse and Varmus, 1992; McMahon, 1992); its expres-
ion is required for the development of a large region of
he mouse brain (McMahon and Bradley, 1990). Further-
ore, Wnt-1 expression in Xenopus embryos has been
ound to promote the duplication of the embryonic axis
McMahon and Moon, 1989).
In addition to its roles in embryonic development and
ouse mammary tumorigenesis, Wnt-1 shows other bi-
logical activities in vitro. Wnt-1 expression has been
ound to induce morphological alterations in one mam-
ary epithelial cell line (Brown et al., 1986) while it
endered another cell line (RAC311C) tumorigenic (Ri-
sewijk et al., 1987). Further, Wnt-1-expressing rat or
ouse fibroblasts that show no detectable response
hemselves can transform neighboring C57BL cells in
oculture experiments. This indicates that the Wnt-1 pro-
ein, a cysteine-rich glycoprotein of 41 to 44 kDa, appar-
ntly acts via a paracrine mechanism (Jue et al., 1992). Its of interest to note that Wnt-1 does not normally accu-
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139Wnt-1 ANTISENSE RNA REVERSES MAMMARY TUMOR GROWTHulate in the tissue culture medium, but instead, is
ecreted onto the surface of cells or into their microen-
ironment (Papkoff et al., 1987; Bradley and Brown, 1990;
apkoff and Schryver, 1990) and seems to be active
hen it exists as a transmembrane protein (Parkin et al.,
993).
Results from one in vivo study in a Wnt-1 transgenic
ouse model have indicated that Wnt-1 expression in
ammary glands confers a direct local growth stimula-
ion of mammary epithelial cells, leading to their acqui-
ition of a preneoplastic state (Lin et al., 1992). This is
onsistent with the finding that the mammary glands of
oung virgin transgenic mice (approximately 3 months
ld) resemble the mammary glands of pregnant non-
ransgenic animals with regard to the development of
lveolar hyperplasias (Tsukamoto et al., 1988). Even the
ammary glands of 2-week-old Wnt-1 mice show alve-
lar hyperplasias (Lin et al., 1992). However, it is still
nknown whether these hyperplastic cells need to be
ontinuously stimulated by the Wnt-1 protein in order for
he cells to be transformed into tumor cells. More impor-
antly, it remains to be established whether or not mam-
ary tumor cells acquire growth autonomy during trans-
ormation or whether they still require continuous ex-
ression of Wnt-1 for their ability to form tumors in vivo
nd subsequently metastasize. These concerns can be
ddressed by reducing the expression of Wnt-1 in pre-
eoplastic and/or neoplastic mammary tumor cell lines
hrough antisense technology and testing whether the
bility of the cells to form tumors in vivo is impaired.
The antisense approach has been successfully ap-
lied by numerous investigators to inhibit the expression
f a variety of target genes, and hence, the activity of the
rotein product (for review see Stein and Cheng, 1993).
or example, the expression of antisense RNA to the
nsulin-like growth factor-1 receptor has been shown to
nduce regression of wild-type rat glioblastoma tumors
Resnicoff et al., 1994), loss of the metastatic phenotype
f the Lewis lung carcinoma line H-59 (Long et al., 1995),
nd suppression of malignant phenotypes of a human
lveolar rhabdosarcoma (Shapiro et al., 1994). Down-
egulation of N-myc1 by antisense RNA in woodchuck
epatoma cells has recently been observed to reverse
he malignant phenotype (Wang et al., 1997). In the
resent study, we have used an antisense approach to
etermine the role of Wnt-1 in the growth in vivo of a
ammary tumor cell line (R/Sa-MT) expressing Wnt-1.
/Sa-MT cells were transfected with vectors designed to
onstitutively express a segment of Wnt-1 RNA in the
ntisense or sense (as control) orientations relative to a
teroid-inducible promoter. Stable transfectants were
solated and tested for tumorigenicity. Our results show
hat the expression of ectopic antisense, but not sense,
nt-1-specific RNA in R/Sa-MT cells resulted in lowering
ignificantly the levels of expression of endogenous
nt-1 mRNA and protein. In addition, the cells lost their ebility to form tumors in mice by more than 90%. Thus, we
uggest that continuous signaling by Wnt-1 protein is
equired for the maintenance of the tumorigenic pheno-
ype of mammary tumor cells in mice.
RESULTS
ormonal regulation of antisense Wnt-1 RNA
xpression and the downregulation of endogenous
nt-1 mRNA
To gain insights into the regulatory role of Wnt-1 in the
rowth of mammary tumors, we transfected a mammary
umor cell line, R/Sa-MT, with two expression vectors,
GRE5-1/Wnt-1(sense, S) and pGRE5-2/tnW-1(antisense,
S) containing a 290-bp segment of the Wnt-1 cDNA (Fig.
), together with pSV2neo plasmid DNA. The rationale for
ur choice of the vectors was that they contained a
ynthetic promoter composed of five high-affinity binding
ites for the glucocorticoid receptor (GRE5) placed up-
tream of the adenovirus 2 major late promoter
Ad2MLP) TATA box/initiation site (Fig. 1). This promoter
as been shown to be at least 50-fold more inducible by
examethasone than the MMTV long terminal repeat
LTR) promoter (Mader and White, 1993). We therefore
FIG. 1. Schematic representation of the construction of sense and
ntisense Wnt-1 expression plasmids. An EcoRI/XhoI fragment contain-
ng the 59 end of the Wnt-1 cDNA was isolated from the plasmid pSP65
third panel) and ligated to the expression vectors pGRE 5-1 (first panel)
nd pGRE 5-2 (second panel) in the sense (fourth panel) and antisense
rientations (fifth panel) at the EcoRI/XhoI and XhoI/EcoRI sites, re-
pectively. The expression vectors pGRE 5-1/5-2 contained a synthetic
romoter composed of five sites for the binding of glucocorticoid
eceptor (GRE) and the adenovirus 2 major late promoter (Ad2) and
ATA box/initiation site.xpected that it would induce high levels of Wnt-1 anti-
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140 LI, PAPKOFF, AND SARKARense RNA, but not endogenous Wnt-1 mRNA, in trans-
ectants exposed to small amounts of dexamethasone.
As shown in Fig. 2, digestion of both the S and the AS
lasmids with EcoRI/XhoI produced a 290-bp fragment
lanes S-E/X and AS-E/X), whereas digestion with EcoRI/
amHI generated 650- (lane S-E/B) and 940-bp (lane
S-E/B) fragments. These results indicate that the S and
S vectors contained the 290-bp Wnt-1 fragment in the
ense and antisense orientations, respectively. Follow-
ng G418 selection of the transfected cells, we isolated a
otal of 23 cell clones. Expansion of these clones and
xamination by Southern hybridization with a Wnt-1
DNA probe resulted in the identification of nine cell
ines (AS-3 to AS-8, AS-12, AS-13, and AS-16) carrying
ne to five copies of the antisense construct and three
ell lines (S-3, S-4, and S-7) that contained one to three
opies of the sense construct. The presence of multiple
opies of an antisense construct (lane 2) and a single
opy of a sense construct (lane 6) in two stably trans-
ected cell lines, AS-13 and S-3, respectively, is shown in
ig. 2B.
FIG. 2. (A) The pattern of restriction fragments of the plasmid con-
tructs S and AS (see Fig. 1) that identifies the DNA clones containing
nt-1 sequences in the sense (S) or in the antisense (AS) orientations.
lasmid DNA was double digested with EcoRI (E) and BamHI (B), or
coRI and XhoI (X), and the fragments were separated by gel electro-
horesis and visualized by ethidium bromide staining. The low-molec-
lar-weight E/X band corresponds to the 290-bp Wnt-1 fragment (Fig. 1)
hat was used to construct the sense and antisense plasmids. The
resence of 650- and 940-bp E/B bands in the corresponding plasmids
ndicate that they contain the 290-bp Wnt-1 fragment in the sense and
ntisense orientations, respectively. (B) Southern blot hybridization with
he Wnt-1 cDNA probe of the EcoRI digests of DNA for the identification
f the R/Sa-MT cell clones that contained Wnt-1 antisense or sense
onstructs. Note that only one (lane 2) of the three antisense clones
lanes 2–4) and one (lane 6) of the two sense (lanes 5 and 6) clones
hown in this figure contained copies of exogenous Wnt-1 sequences.
he 8.0-kb band corresponds to the endogenous EcoRI/Wnt-1 frag-
ent. Lane 1 contained control R/Sa-MT cell DNA. Lane 2, clone AS-13;tane 6, clone S-3.To ascertain the responsiveness of antisense and
ense constructs to dexamethasone, AS-8, AS-13, and
S-16 cell lines were treated with varying concentrations
f the hormone, total cellular RNA was extracted, and the
evels of the antisense and sense RNAs were evaluated
y RT-PCR. We found that the AS-13 cell line expressed
mall amounts of antisense Wnt-1 RNA and that the
evels of the RNA increased with hormonal treatment
Figs. 3A and 3B). Similar results were obtained with the
S-8 cell line (data not shown). In comparison with the
ontrol cells, the AS-13 cells treated with as little as 25
M/ml (equivalent to 6.8 ng/ml) of dexamethasone for a
eriod of 24 h resulted in an approximately 10-fold in-
rease in the amount of antisense RNA (ASR; Fig. 3A,
ane 5, and Fig. 3B, lane 6). The basal levels of endoge-
ous Wnt-1 mRNA expression were found to be high in
oth the control R/Sa-MT (lane 1, Figs. 3A and 3B) and
he transfected AS cells (lane 2, Figs. 3A and 3B). Treat-
ent of the AS cells with increasing concentrations of
FIG. 3. (A) The expression pattern, as evaluated by RT-PCR, of Wnt-1
ntisense RNA (ASR) in pGRE5-2/tnW-1 transfected R/Sa-MT cells
AS-13) and its effect on the blocking of Wnt-1 mRNA (mRNA) expres-
ion in response to a 24-h exposure to different concentrations (0–200
M) of dexamethasone (Dex). (B) The time course of induction of Wnt-1
ntisense RNA by 25 nM dexamethasone. M, molecular weight marker;
ane 1 contained RT-PCR of control R/Sa-MT cell RNA. The lane des-
gnated R contained the RT-PCR product made from the RNA of
/Sa-MT cells in the absence of RT. The RT-PCR of actin mRNA (actin)
as used as control.he hormone resulted in increased expression of anti-
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141Wnt-1 ANTISENSE RNA REVERSES MAMMARY TUMOR GROWTHense Wnt-1 RNA, and as a consequence the levels of
he Wnt-1 mRNA decreased. The optimum concentration
f the hormone was found to be 25 nM. It should be
ointed out that this low concentration of hormone did
ot increase the levels of Wnt-1 mRNA despite the fact
hat the expression of the gene in these cells is under the
egulation of an MMTV LTR that contains hormone re-
ponsive elements (data not shown). This is due to the
act that the MMTV LTR responds to a higher concentra-
ion (1–10 mg/ml, i.e., 3.7–37 mM) of dexamethasone
Ringold et al., 1975; Sarkar et al., 1977).
To define the optimum time of dexamethasone expo-
ure for maximum induction of antisense RNA, the AS-13
ell line was treated with a 25 nM concentration of the
ormone for various time periods and the levels of the
xpression of antisense RNA were evaluated by RT-PCR.
he results indicated that the maximum amount of anti-
ense RNA was induced with 20 to 30 h of hormonal
xposure (Fig. 3B). The effects of dexamethasone treat-
ent for a period of 24 h on the expression of Wnt-1
FIG. 4. (A) The effect, as determined by RT-PCR, of antisense Wnt-1
NA (ASR) expression on the levels of the expression of Wnt-1 mRNA
mRNA) in two different antisense clones of R/Sa-MT cells (AS-8 and
S-13) grown to confluency in the presence (1Dex) or absence (2Dex)
f 25 nM dexamethasone for a period of 24 h. R/Sa-MT cell RNA was
sed as a positive control, whereas the RNA from S-3 cells (sense
lone) served as a negative control. (B) Northern blot hybridization with
Wnt-1 cDNA probe of RNA obtained from a number of dexametha-
one (25 nM) treated R/Sa-MT cell lines containing sense (S-3) and
ntisense (AS-4, AS-8, AS-12, AS-13) constructs and from several
ouse tissues (MG, mammary gland). Note that the presence of Wnt-1
RNA is significantly lower in the antisense clones than in the
/Sa-MT (control) cells and cells that contained Wnt-1 sense con-
tructs. Actin probe was used as a control to indicate uniform loading
f RNA.ntisense and Wnt-1 mRNA in two clonal cell lines trans- eected with an antisense construct and in one cell line
arrying a sense construct are shown in Fig. 4A. Com-
ared to the control (RIII/Sa-MT) and the sense (S-3) cell
ines, the hormone-treated antisense cell lines (AS-8 and
S-13) expressed approximately 7.8-fold more antisense
NA than the untreated AS-8 and AS-13 cells, and ac-
ordingly, the levels of endogenous Wnt-1 mRNA expres-
ion were dramatically reduced. These observations
ere confirmed further by Northern blot hybridization
ith a cDNA Wnt-1 probe of total RNA obtained from
ormone-treated cells (Fig. 4B). The steady-state levels
f Wnt-1 mRNA expression in the antisense cell lines
S-4, AS-12, AS-8, and AS-13 were found to be reduced
y 91, 72, 89, and 84%, respectively, compared to the
ense cell line S-3 or the control cell line. Similarly, the
mall tumors (see below) that were induced by the anti-
ense cell lines expressed significantly much smaller
mounts (80–90%) of Wnt-1 mRNA than the tumors pro-
uced by the sense or the control cell lines (data not
hown).
he effect of antisense RNA on Wnt-1 protein
xpression
To determine whether the AS-8 and AS-13 cells carry-
ng antisense constructs might fail to accumulate Wnt-1
rotein, compared to cells carrying the sense constructs,
ell extracts were prepared and subjected to immuno-
recipitation with an appropriate anti-Wnt-1 peptide an-
iserum (see Materials and Methods). Quantitation of the
mmunoprecipitates following SDS–PAGE revealed that
he amounts of Wnt-1 protein contained in the AS-8 and
S-13 cell lines were approximately 23.1 and 11.3%, re-
pectively, of the amount of protein accumulated in the
-3 cell line (Fig. 5) or in the control cell line (data not
hown). These observations are in close agreement with
he levels of Wnt-1 mRNA expressed in these cell lines.
he effect of antisense RNA on cell growth and cell
orphology
Assessment of the pattern of cell growth in vitro re-
ealed that, in general, the antisense cell lines grew at a
omewhat slower rate than the control (R/Sa-MT cell
ine) and the sense cell lines (Fig. 6). However, continu-
us dexamethasone (25 nM) treatment reduced signifi-
antly the growth rate of the antisense cell lines com-
ared to the control and the sense cell lines. In the
resence of the hormone, the antisense cell lines grew
rimarily in colonies and did not reach confluency. While
he control and the sense cell lines with a seeding
ensity of approximately 2 3 106/75 cm2 required pas-
aging within 5 days, the antisense cells remained sta-
ionary for up to 9 days with no appreciable cell loss.
The R/Sa-MT cells expressing Wnt-1 mRNA exhibited,
rior to or at confluency, epithelioid morphology with
longated cytoplasm (Figs. 7A and 7E). Continuous ex-
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142 LI, PAPKOFF, AND SARKARosure of the cells to 25 nM dexamethasone did not
ffect the appearance of the cells (Figs. 7I and 7M). The
orphology of the cells transfected with a Wnt-1 sense
onstruct and grown in the absence (Figs. 7B and 7F) or
n the presence (Figs. 7J and 7N) of dexamethasone
esembled the nontransfected control cells (Figs. 7I and
M). In contrast, the cells that were transfected with an
ntisense Wnt-1 construct displayed distinct morpholog-
cal changes. In the absence of hormone, 1-day-old (Fig.
C) or 2-day-old (Fig. 7G) cultures resembled the control
ells, but with time some of the cells began to grow in
istinct colonies (Figs. 7K and 7O). At confluency, about
0% of the cells exhibited this phenotype. Dexametha-
one treatment of the cells showed profound changes in
orphology; within 2–3 days postplating, the cells ap-
eared to be organized into distinct foci or colonies of
arious sizes (Figs. 7H and 7L). Stationary cultures pri-
arily showed the presence of cells with smaller
mounts of cytoplasm (Fig. 7P); only a minor proportion
f the cells (,5%) still showed extended cytoplasm.
hese observations clearly indicate that Wnt-1 antisense
NA expression profoundly affected the morphology of
he Wnt-1 RNA-expressing R/Sa-MT cells and that this
ffect seems to be directly related to the antisense
FIG. 5. Comparison of Wnt-1 protein levels in mouse mammary tumor
ells transfected with antisense (AS-13 and AS-8) and sense (S-3)
nt-1 constructs. Cells were labeled with [35S]cysteine, cell extracts
ere prepared, and samples of each cell extract containing equivalent
mounts of 35S counts/minute were immunoprecipitated with 2 ml JP4
ntiserum (A, lanes 1, 3, and 5). Cell extracts were also immunopre-
ipitated with serum preabsorbed with synthetic Wnt-1 peptide (lanes
, 4, and 6). (B) The relative amounts of Wnt-1 protein that were
vailable for immunoprecipitation (IMP) from each of the three cell
ines. An arbitrary unit of 100 was assigned to the density of the protein
iand corresponding to the sense cell line S-3.ownregulation of the levels of endogenous Wnt-1 mRNA
nd protein.
he effect of Wnt-1 antisense RNA expression on the
umorigenicity of R/Sa-MT cells
To evaluate the biological consequences of the down-
egulation of Wnt-1 mRNA and protein in cells containing
ntisense Wnt-1 constructs, we tested the tumorigenicity
f the antisense cell lines AS-8 and AS-13 in RIII/Sa mice.
/Sa-MT cells transfected with sense constructs (S-3)
nd nontransfected cells were also used as controls.
epresentative data from these experiments are shown
n Table 1. About 10% of the mice inoculated with
/Sa-MT cells, irrespective of dexamethasone treatment,
eveloped palpable tumors within a week, and all mice
howed palpable tumors by 3 weeks. Growth patterns of
he tumors from cells transfected with sense constructs
nd from control cells were found to be very similar. By
ontrast, most of the mice inoculated with cells express-
ng antisense RNA did not show palpable tumors until
–4 weeks postinoculation. Dexamethasone treatment of
hese animals appeared to cause some delay in the
ppearance of the tumors. For example, it took approxi-
ately 9 weeks for all of the hormone-treated animals to
evelop tumors compared to a period of 6 weeks for the
ntreated mice.
The profound inhibitory effect of antisense RNA on
umor growth became apparent when the average sizes
f the tumors extracted from the different groups of mice
ere compared (Table 1). Mice transplanted with anti-
ense RNA expressing cells and treated with dexameth-
sone produced tumors no larger than 0.3 cm in diam-
ter, even after a period of 16 weeks (Fig. 8B). Under
FIG. 6. In vitro growth patterns of sense (S-3) and antisense (AS-13)
ell lines unexposed (S and AS) or exposed (S 1 Dex, AS 1 Dex)
ontinuously to 25 nM dexamethasone (Dex). Triplicate cultures were
sed for each time point. Each culture dish (75 cm2) was seeded with
3 106 cells.dentical conditions, the control groups of mice produced
D
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143Wnt-1 ANTISENSE RNA REVERSES MAMMARY TUMOR GROWTHFIG. 7. The morphology of control (nontransfected) R/Sa-MT cells (A, E, I, and M) and of cells containing sense (B, F, J, and N) and antisense (C,
, G, H, K, L, O, and P) Wnt-1 constructs as observed after 1 (A–D), 2 (E–H), 3 (I–L), and 4 (M–P) days postplating of 3 3 106 cells in a 75-cm2 dish.
ome of the cultures were treated continuously with 25 nM dexamethasone (D, H, I, J, L, M, N, and P). Note that the cells that were expressing low
evels of antisense transcripts (in the absense of dexamethasone) exhibited some alterations in morphology as the cultures became confluent (K and
). Such a change in cell morphology became more pronounced with increased expression of the Wnt-1 antisense RNA as a consequence of
examethasone treatment (L and P). It should be noted that P represents the appearance of a large colony of cells.
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144 LI, PAPKOFF, AND SARKARarge tumors, 1.8 to 2.4 cm in diameter, within 8 weeks
Fig. 8A). It is of interest to note that these tumors grew
ery rapidly and were often found to be composed of
ultiple segments.
DISCUSSION
We have demonstrated in the present study that the
bility of a tumor cell line (R/Sa-MT) to form tumors in
ivo can be modulated by transfecting the cells with a
lasmid construct containing Wnt-1 sequences in the
ntisense orientation. The R/Sa-MT cell line expresses
nt-1 mRNA and protein and produces large tumors
.2.0 cm in diameter) in syngeneic mice within a period
f 8 weeks (Table 1). Compared to these cells, or to cells
hat were transfected with a plasmid DNA containing
nt-1 sequences in the sense orientation, the antisense
xpressing cells (R/Sa-MT/antisense) took twice the
mount of time to form palpable tumors (6–8 weeks vs
–4 weeks) and the tumors they formed were 80–90%
maller in diameter. Our analyses by RT-PCR of the
xpression of Wnt-1 antisense RNA and Wnt-1 mRNA in
he R/Sa-MT/antisense cells were not quantitative; how-
ver, qualitatively, the levels of the respective RNAs were
ound to be inversely proportional (see Figs. 3A, 3B, and
A). Furthermore, the RT-PCR results correlated very
losely with those obtained by Northern hybridizations
Fig. 4B). These observations, therefore, suggest that the
T
The Effect of Sense and Antisense Wnt-1 RNA
ells transfected with
or without Wnt-1
constructs
No. of mice
inoculated
(Dex 6)a
Time for th
Ta
/Sa-MT 1 none 16 (Dex2) 1
/Sa-MT 1 none 16 (Dex1) 1
/Sa-MT 1 sense
(cl. S-3) 21 (Dex2) 1
/Sa-MT 1 sense
(cl. S-3) 18 (Dex1) 1
/Sa-MT 1 antisense
(cl. As-8) 26 (Dex2) 3
/Sa-MT 1 antisense
(cl. As-8) 25 (Dex1) 4
/Sa-MT 1 antisense
(cl. As-13) 13 (Dex2) 3
/Sa-MT 1 antisense
(cl. As-13) 15 (Dex1) 4
a Mice were treated with (Dex 1) or without (Dex 2) dexamethason
b Ta, time (weeks) postinoculation for the earliest appearance of pa
eveloped tumors; T100, the time when 100% of the mice had develope
c Animals were sacrificed at the end of 8, 12, or 16 weeks postinocu
earing animals had to be sacrificed as soon as tumor size reached ap
iffer significantly (P , 0.001).rimary effect of antisense Wnt-1 expression is the aownregulation of Wnt-1 mRNA; the antisense RNA most
ikely blocked Wnt-1 transcription as a result of its inter-
ction with the sense strand DNA. The possibility re-
ains that the antisense RNA also may have blocked the
ransfer of Wnt-1 pre-mRNA to the cytoplasm. It should
e mentioned that currently, the mechanism of action of
n antisense gene is not well understood, but it has been
peculated that antisense expression may interfere with
he functioning of a gene at the level of RNA transcrip-
ion, processing, transport, translation, or mRNA stability
Izant, 1992).
The presence of smaller amounts of Wnt-1 protein in
he antisense cell lines, compared to the normal and
ense cell lines (Figs. 5A and 5B), seems to account for
he loss of the highly tumorigenic phenotype of the
/Sa-MT cells (Table 1). In general, we observed close
orrespondence between the copy number of the inte-
rated antisense construct contained in different anti-
ense cell lines, the levels of antisense RNA expression,
he presence of Wnt-1 mRNA and protein in the corre-
ponding cell lines, and the efficiency of the clones to
orm tumors in vivo. However, the relationship between
he extent of antisense downregulation of Wnt-1 mRNA/
rotein and the growth rate of the antisense cells in vivo
as found to be nonlinear. For example, the antisense
lone 13 contained more copies (seven copies) of the
ntisense DNA than the antisense clone 8 (three copies)
ssion on the Tumorigenicity of R/Sa-MT Cells
arance of tumor
s)b Tumor load
T100
Time of sacrifice
(weeks)c
Tumor size
(cm)
3 8 2.0 6 0.3a
3 8 2.1 6 0.3a
4 8 2.1 6 0.4a
4 8 2.1 6 0.4a
8 12 1.9 6 0.2a
9 16 0.3 6 0.1b
6 12 1.5 6 0.2a
9 16 0.2 6 0.1b
g/g of body weight/day).
tumors in each group of mice; T50, the time when 50% of the mice
rs.
he different time periods were chosen because of the fact that tumor
ately 2.0 cm in diameter. Tumor sizes noted by dissimilar superscriptsABLE 1
Expre
e appe
(week
T50
1.5
1.5
2.0
2.0
5.0
7.0
5.0
6.0
e (10 n
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145Wnt-1 ANTISENSE RNA REVERSES MAMMARY TUMOR GROWTHRNA/protein (Figs. 4B and 5) than clone 8, yet both cell
ines produced tumors of similar sizes (Table 1). These
bservations indicate that there may be a threshold
etween the level of Wnt-1 mRNA/protein expression
nd the ability of the cells to develop tumors. This notion
ay provide an explanation, at least in part, for the
ariability observed by many investigators in the levels of
xpression of Wnt-1 mRNA and other int protoonco-
enes, such as Fgf-3 (int-2) and int-3, among most, if not
ll, spontaneously developed mammary tumors of mice
for references see Sarkar, 1995). The other factor that
ay account for these variations is the polyclonality of
ndividual tumors with respect to the activation of the int
enes (Sarkar, 1995).
Inappropriate expression of Wnt-1 has been attributed
o the transformation of normal mammary epithelial cells
nto preneoplastic and neoplastic cells. Wnt-1 also
eems to play an important role in the development of
ouse as well as Xenopus embryos (McMahon and
radley, 1992; McMahon and Moon, 1989). Since coordi-
ated cell proliferation and maintenance of close asso-
iation between groups of cells via cell–cell adhesion
re essential in development (Gerhart and Keller, 1986),
t is reasonable to assume that Wnt-1 may act in vivo not
nly as a regulator of cell proliferation and differentiation,
ut also as a modulator of cellular contacts. The conse-
uences of ectopic Wnt-1 expression in a number of cell
ines have been examined (Brown et al., 1986; Rijsewijk
t al., 1987; Jue et al., 1992). Wnt-1 expression was found
o alter the cell morphology of one normal mammary
pithelial cell line (C57BL) from a flat, cuboidal type to
FIG. 8. The appearance of mammary tumors produced by control R/Sa
as injected with 5 3 106 cells subcutaneously on the same day, and f
M/mouse). The mouse in A was sacrificed after 8 weeks, while the m
he largest of the tumors that developed in the two respective groups of
oint to individual tumor lobes.longated, refractile, fibroblast-like cells (Brown et al.,986; Jue et al., 1992). The cells, although not fully trans-
ormed, showed another phenotypic change: unlike the
ontrol cells, they acquired the ability to divide in culture
eyond confluency and to exhibit increased calcium-
ependent cell–cell adhesion (Brown et al., 1986; Jue et
l., 1992; Hinck et al., 1994b).
Ectopic Wnt-1 expression in a mammary tumor cell
ine that had a MMTV integration at the Fgf-3 locus, but
ot at the Wnt-1 locus, showed some changes in cell
rowth and morphology; the cells grew to a higher den-
ity, they showed disordered, criss-cross patterns, and
heir shape changed from a cuboidal to an elongated
ype (Rijsewijk et al., 1987). Interestingly, Wnt-1 expres-
ion has also been observed to cause morphological
hanges in one nonmammary, neural crest-derived tu-
or cell line PC12 (Bradley et al., 1993; Shackleford et al.,
993b). Unlike the control cells, the Wnt-1 expressing
C12 cells (PC12/Wnt-1) were found to grow in discrete
olonies of adherent cells with an epitheloid appear-
nce. Similarly, as shown in the present study, antisense
ownregulation of Wnt-1 seemed to induce significant
henotypic changes in the morphology of the R/Sa-MT/
ntisense cells in vitro. The Wnt-1 expressing cells (R/
a-MT) appeared to be elongated and disordered,
hereas the cells in which endogenous Wnt-1 expres-
ion was blocked exhibited cuboidal morphology (Fig. 7).
he most important aspect of our finding is the causal
ssociation between the levels of Wnt-1 mRNA/protein
xpression, morphological changes, and tumorigenicity
f the cell lines. However, the signal transduction path-
ay of Wnt-1 in our cell line remains unknown.
lls (A) and cells expressing Wnt-1 antisense transcript (B). Each mouse
third day on, each mouse was injected daily with dexamethasone (25
B was sacrificed after 16 weeks. A and B represent the smallest and
ls. The black curved arrows outline the tumors; the small white arrows-MT ce
rom the
ouse in
animaThere are strong indications that the protein encoded
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146 LI, PAPKOFF, AND SARKARy Wnt-1 acts as an intracellular signaling molecule, as
o the transforming growth factors (TGFs) (Massague,
992; Moses, 1990) and fibroblast growth factors (FGFs)
Burgess and Maciag, 1989; Klagsburn, 1989; Rifkin and
oscatelli, 1989). A number of studies have shown that
ctopic expression of Wnt-1 results in the accumulation
f plakoglobin and/or b-catenin in some cells (Bradley et
l., 1993; Funayama et al., 1995; Hinck et al., 1994a, b;
apkoff et al., 1996). Furthermore, Wnt-1 expressing
C12 cells show increased levels of plakoglobin and
-cadherin and increased levels of calcium-dependent
ell–cell adhesion (Bradley et al., 1993). These findings
uggest that b-catenin and plakoglobin may be the tar-
ets of the Wnt-1 signal transduction cascade. Since
-catenin and plakoglobin bind to the cytoplasmic do-
ain of the cadherin family of cell adhesion molecules
Nagafuchi and Takeichi, 1988; Knudsen and Wheelock,
992; Piepenhagen and Nelson, 1993), it is likely that
nt-1 functions through b-catenin and plakoglobin in
liciting morphogenetic changes in cells. In this pathway,
he involvement of glycogen synthase kinase 3b (GSK3b)
nd the T cell factor/lymphocyte enhancer binding factor
as been suggested (Cook et al., 1996; Behrens et al.,
996; Porfiri et al., 1997; Papkoff and Aikawa, 1998;
usse, 1997). Wnt-1-induced cell fate determination may
lso involve the participation of Engrailed-1 (Danielian
nd McMahon, 1996) and the gap-junctional protein con-
exin 43 (van der Heyden et al., 1998).
At present, it is virtually unknown whether or not
hanges in b-catenin/plakoglobin and/or connexin 43
xpression may affect the growth potential of Wnt-1-
nduced mammary tumor cells in vivo. In this context, it
hould be noted that abnormal expression of E-cadherin,
modulator of the cytoplasmic pools of b-catenin, has
een found to occur frequently in adenocarcinomas such
s breast cancer, gastric cancer, and prostate cancer
see Voeller et al., 1998). As shown in the present study,
ur R/Sa-MT cell line is highly tumorigenic, and there-
ore, it could be used as an ideal model system for the
dentification of the downstream molecules that are in-
olved in the Wnt-1 signal transduction pathway during
umorigenesis of the mouse mammary glands. We are
urrently interested in determining whether or not anti-
ense downregulation of b-catenin/plakoglobin and/or
onnexin 43 will modulate the tumorigenic phenotype of
his cell line in a manner similar to what we have ob-
erved with the downregulation of Wnt-1.
MATERIALS AND METHODS
lasmid construction
The coding region of the Wnt-1 gene is composed of
our exons with a single open reading frame that en-
odes a protein of 370 amino acids (Fung et al., 1985).
he mode of action of antisense RNA-mediated inhibition
f gene expression presumably involves hybridization of fntisense RNA to a target mRNA (Freir et al., 1992). It is
herefore desirable that the sequences targeted for the
ntisense RNA do not contain stem loop structures con-
aining more than 6-bp stems. On the basis of the sec-
ndary structural analysis of Wnt-1 cDNA (using the CCG
rogram from Genetic Computer Group, Inc.), we se-
ected a 290-bp segment of Wnt-1 that contained the
nitiation codon for Wnt-1 protein (Fung et al., 1985). This
egment of Wnt-1 was released by digestion with EcoRI
nd XhoI from pSP65 plasmid DNA that contained a copy
f full-length Wnt-1 cDNA (Fig. 1). The digested DNA was
ubjected to preparative electrophoresis in a 1.2% aga-
ose gel and the appropriate fragment was isolated by
lectroelution and ligated separately into the eukaryotic
xpression vectors pGRE5-1 and pGRE5-2 (kindly pro-
ided by Sylvie Mader of McGill University, Canada;
ader and White, 1993) at the EcoRI/XhoI and XhoI/
coRI cloning sites to create Wnt-1 sense (pGRE5-1/
nt-1) and antisense (pGRE/tnW-1) constructs, respec-
ively.
issue culture and cell transfection
The mammary tumor cell line (R/Sa-MT) used in this
tudy was established in our laboratory from a lung
odule that developed in an RIII/Sa mouse carrying a
ransplantable metastatic mammary tumor. This epithe-
ial cell line expresses constitutively high levels of Wnt-1
RNA and protein as a consequence of insertional mu-
ation of the oncogene by a MMTV provirus. Transplan-
ation of R/Sa-MT cells in syngeneic male or female mice
esults in rapid tumor development. A full characteriza-
ion of this cell line will be reported elsewhere. Routine
ell cultures were done in Dulbecco’s modified Eagle’s
edium (DMEM) containing 10% (v/v) fetal calf serum,
onessential amino acids, L-glutamine, vitamins, and an-
ibiotics. Cell cultures were maintained at 37°C in a
umidified atmosphere of 5% CO2.
The pGRE5-1/Wnt-1 and pGRE5-2/tnW-1 plasmid
NAs, carrying the sense and antisense Wnt-1, respec-
ively, were cotransfected with pSV2neo (Southern and
erg, 1982) plasmid DNA into the R/Sa-MT cells using
he standard calcium phosphate (CaPO4) transfection
rocedure (Chen and Okayama, 1988). A total of 30 mg
NA at a 20:1 molar ratio of sense/antisense to pSV2neo
NA was used for each transfection. The transfected
ells were then cultured from day 2 onward in the same
edium, but supplemented with 400 mg/ml of G418 (Ge-
eticin; Gibco Laboratories, Grand Island, NY) in order to
elect stable transfectants. After 12–14 days, G418-resis-
ant colonies were isolated and replated in fresh medium
or the expansion of the clones.
etermination of cell growth
Equal numbers of cells (1 or 2 3 106/75-cm2 dishes)
rom the parental, antisense, and sense cell lines were
s
i
h
l
I
t
w
R
c
E
A
v
t
u
w
t
m
p
c
p
d
m
o
e
i
2
e
S
c
u
(
w
a
C
w
a
t
N
g
e
a
v
P
s
U
i
t
S
w
o
6
r
t
b
o
R
w
M
m
D
e
(
w
c
w
(
D
m
p
t
5
T
p
a
o
A
2
9
a
6
b
g
p
f
G
t
s
(
s
c
T
5
r
G
p
N
I
W
147Wnt-1 ANTISENSE RNA REVERSES MAMMARY TUMOR GROWTHeeded and cultured for various days in the presence or
n the absence of dexamethasone (25 nM). Cells were
arvested by trypsinization, resuspended in isotonic di-
uent, and counted with a hemocytometer.
noculation of mice
To compare the tumorigenicity of the R/Sa-MT cells
ransfected with sense or antisense Wnt-1 constructs, as
ell as control cells, eight groups of 4- to 6-week-old
III/Sa (Sarkar, 1995) mice were inoculated. Monolayer
ultures were trypsinized with 0.05% trypsin in 0.01%
DTA and the cells were counted with a hemocytometer.
pproximately 5 3 106 cells suspended in a minimum
olume (100–200 ml) of ice-cold PBS were injected into
he fourth inguinal mammary fat pads of mice. The inoc-
lated mice were maintained under identical conditions
ith respect to environment, diet, and handling except
hat four groups of mice were inoculated daily with 20–25
l of solution containing predetermined amounts (10 ng
er gram of body weight) of dexamethasone while the
ontrol groups were inoculated with solvent. The fat
ads of each mouse were palpated daily from the fifth
ay postinoculation for the appearance of tumors. The
ice continued to be under daily observation for a period
f 16 weeks and the approximate size of tumors was
stimated on a weekly basis with a Vernier caliper. Dur-
ng this time period, those mice that had tumors close to
.0 cm in diameter were sacrificed, their tumors were
xcised, and the size of the tumors was determined.
outhern analysis
Ten micrograms of DNA isolated from each of the
lonal cell lines was digested to completion using EcoRI
nder conditions recommended by the manufacturer
New England Biolabs Inc., Beverly, MA). Digested DNA
as electrophoresed in a 0.8% Tris–acetate agarose gel
nd transferred to nylon filter (Hybond-N; Amersham
orp., Arlington Heights, IL). The filter was hybridized
ith a [32P]dCTP-labeled Wnt-1 cDNA probe, washed,
nd exposed to Kodak XAR film following the procedure
hat we have used previously (Sarkar, 1995).
orthern hybridization
Total cellular RNA was extracted from exponentially
rowing cells with 6 M urea–3 M LiCl, denatured, and
lectrophoresed in 1% agarose gel (20 mg RNA/lane)
ccording to the procedure that we have described pre-
iously (Li et al., 1994). RNA was transferred to Zeta
robe filters in the presence of 203 SSC (13 SSC con-
ists of 0.15 M NaCl, 0.015 M sodium citrate, pH 7.0) and
V cross-linked. The filters were hybridized with approx-
mately 5 3 107 cpm/ml of radioactive probes in a mix-
ure containing 0.2 M Na2HPO4, 1 mM EDTA, 1% BSA, 7%
DS, and 16% formamide for 24 h at 65°C. The filters
ere then washed three times, 25 min each, in a solution kf 0.04 M Na2HPO4, 5% SDS, and 0.001 mM EDTA at
5°C and exposed to Kodak X-ray film at 280°C. The
adioactive probe was then stripped (dehybridized) from
he filter and the filter was rehybridized with a chicken
-actin probe in order to ensure that equivalent amounts
f RNA were loaded on each lane of the gel.
everse transcriptase and RT-PCR
Two micrograms of total cellular RNA was digested
ith 2 U of RQ1 RNase-free DNase (Promega Corp.,
adison, WI) in the presence of 20 U of RNasin (Pro-
ega Corp.) in 10 ml at 37°C for 15 min followed by
Nase inactivation at 95°C for 2 min. To detect the
xpression of Wnt-1 antisense RNA, the sense primer
forward) was used in a reverse transcription reaction,
hile the antisense primer (reverse) was used to detect
ellular Wnt-1 mRNA. The reverse transcriptase reaction
as performed with 5 U of AMV reverse transcriptase
Promega) in 50 mM Tris–Cl, pH 8.3, 50 mM KCl, 10 mM
TT, 5 mM MgCl2, 0.5 mM spermidine, 20 U RNasin, 0.2
M each dNTP, and 10 pmol of antisense or sense
rimers for 60 min at 42°C in a final volume of 20 ml. Of
he resulting cDNA, 4 ml was used for a PCR containing
0 mM KCl, 2.5 mM MgCl2, 10 mM Tris–Cl (pH 9.0), 0.1%
riton X-100, a 0.2 mM concentration of each dNTP, 16
mol (100 ng) of each of the Wnt-1 or b-actin primers,
nd 1 U of Taq polymerase (Promega) at a final volume
f 50 ml.
Amplification of Wnt-1 cDNA was done with a Gene-
mp PCR System 9600 (Perkin–Elmer, Foster City, CA) for
7 cycles according to the following program: 20 s at
5°C, 20 s at 65°C, and 15 s at 72°C. The program for the
mplification of b-actin was 27 cycles of 95°C for 20 s,
2°C for 20 s, and 72°C for 35 s. Samples were analyzed
y electrophoresing 25 ml of each product in 2% agarose
els and staining with ethidium bromide. The following
rimers were used for RT-PCR: for Wnt-1 cDNA, the
orward primer sequence was 59(204)-GCCCAGCTGG-
TTTCTACTAC(224)-39 (also used for reverse transcrip-
ion of Wnt-1 antisense RNA), and the reverse primer
equence was 59(311)-AGGAGGCTATGTTCACGATGC-
290)-39 (also used for cellular Wnt-1 mRNA reverse tran-
cription). The expected size of the amplified Wnt-1
DNA product from reverse transcription was 107 bp.
he primers for b-actin were forward primer sequence,
9 (389)-TGACGGGGTCACCCACACTGTGCCCATCTA(419)-39;
everse primer sequence, 59 (1050)-CTAGAAGCACTTGC-
GTGCACGATGGAGGG(1021)-39. The size of the b-actin
roduct was expected to be 661 bp (GenBank Accession
o. 03765).
mmunoprecipitation
Metabolic labeling of cells and immunoprecipitation of
nt-1 protein were done as previously described (Pap-off et al., 1987; Bradley and Brown, 1990; Papkoff and
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148 LI, PAPKOFF, AND SARKARchryver, 1990). Briefly, cells were grown to subconflu-
ncy (60-mm dish) in DMEM containing 20 nM/ml of
examethasone, washed with phosphate-buffered saline
PBS), and incubated for 30 min in cysteine-free DMEM.
he dishes were then replenished with fresh medium
ontaining 500 mCi of [35S]cysteine (Amersham Corp.),
ncubated for 2 h, washed, and reincubated in the pres-
nce of dexamethasone for an additional period of 4 h.
fter two rinses in PBS, the cells were lysed at 4°C in 1
l of RIPA buffer composed of 0.01 M sodium phosphate,
.15 M NaCl, 1% Nonidet-P40, 1% sodium deoxycholate,
.1% sodium dodecyl sulfate (SDS), and 1% aprotinin. The
ell extracts were centrifuged in a microfuge for 15 min at
°C, and the supernatants were immunoprecipitated in a
olume of 300 ml for 2 h on ice with 2 ml of JP4 antiserum
irected against Wnt-1 peptide residues 275 to 289 (Pap-
off et al., 1987).
Immunoprecipitation of cell extracts was also done
ith JP4 antiserum that was preincubated with the ap-
ropriate peptide (1 mg/1 ml serum) for 30 min. Following
mmunoprecipitation, 1 mg of protein A–Sepharose
Boehringer Mannheim Biochemicals) was then added to
ach sample and the reaction mixtures were mixed pe-
iodically at 4°C for 45 min. The protein A–Sepharose–
ntibody complexes were pelleted through 300 ml of
IPA buffer plus 10% sucrose in a microfuge and washed
nce with the RIPA buffer. The pellets were then sus-
ended in 23 sample buffer (125 mM Tris–hydrochloride,
% SDS, 10% b-mercaptoethanol, 10% glycerol), boiled
or 2 min, and loaded onto SDS–15% polyacrylamide
els. After electrophoresis, the gels were fixed in 10%
cetic acid–25% methanol, treated with Amplify (Amer-
ham), dried, and fluorographed. The intensity of the
adioactive signals was quantified using a Molecular
nalyst software program (Bio-Rad Laboratories).
ACKNOWLEDGMENTS
This work was partially supported by grants from the American
nstitute for Cancer Research (92B31) and the American Cancer Society
BC-494). Y. X. Li was supported in part by a Fogarty International
ellowship (7 F05 TW04695-02 ICP). Thanks are due to A. Mahmoud for
he preparation of the manuscript and to R.-B. Markowitz for editorial
elp.
REFERENCES
ehrens, J., von Kries, J. P., Kuhl, M., Bruhn, L., Wedlich, D., Grosschedl,
R., and Birchmeier, W. (1996). Functional interaction of b-catenin with
the transcription factor LEF-1. Nature 382, 638–642.
radley, R. S., and Brown, A. M. C. (1990). The proto-oncogene int-1
encodes a secreted protein associated with the extracellular matrix.
EMBO J. 9, 1569–1575.
radley, R. S., Cowin, P., and Brown, A. M. C. (1993). Expression of Wnt-1
in PC12 cells results in modulation of plakoglobin and E-cadherin
and increased cellular adhesion. J. Cell. Biol. 123, 1857–1866.
rown, A. M. C., Wildin, R. A., Prendergast, T. J., and Varmus, H. E.
(1986). A retrovirus vector expressing the putative mammary onco-
gene int-1 causes partial transformation of a mammary epithelial cell
line. Cell 46, 1001–1009.urgess, W. H., and Maciag, T. (1989). The heparin-binding (fibroblast)
growth factor family of proteins. Annu. Rev. Biochem. 58, 575–606.
hen, C., and Okayama, H. (1988). Calcium phosphate-mediated gene
transfer: A highly effective system for stably transforming cells with
plasmid DNA. Biotechniques 6, 632–688.
ook, D., Fry, M. J., Hughes, K., Sumathipala, R., Woodgate, J. R., and
Dale, T. C. (1996). Wingless inactivates glycogen synthase kinase-3
via an intracellular signalling pathway which involves a protein ki-
nase C. EMBO J. 15, 4526–4536.
anielian, P. S., and McMahon, A. P. (1996). Engrailed-1 as a target of
the Wnt-1 signalling pathway in vertebrate midbrain development.
Nature 383, 332–334.
ickson, C., Smith, R., Brookes, S., and Peters, G. (1984). Tumorigenesis
by mouse mammary tumor virus: Proviral activation of a cellular gene
in the common integration region int-2. Cell 37, 529–536.
reir, S. M., Lima, W. F., Sanghvi, Y. S., Vickers, T., Zounes, M., Cook,
P. D., and Ecker, D. J. (1992). Thermodynamics of antisense oligonu-
cleotide hybridization. In “Gene Regulation: Biology of Antisense RNA
and DNA” (R. P. Erickson and J. G. Izant, Eds.), Raven Press Series on
Molecular and Cellular Biology, Vol. 1, pp. 95–107. Raven Press, New
York.
unayama, N., Fagotto, F., McCrea, P., and Gumbiner, B. M. (1995).
Embryonic axis induction by the armadillo repeat domain of b-cate-
nin: Evidence for intracellular signalling. J. Cell. Biol. 128, 959–968.
ung, Y.-K. T., Shackelford, G. M., Brown, A. M. C., Sanders, G. S., and
Varmus, H. E. (1985). Nucleotide sequence and expression in vitro of
cDNA derived from mRNA of int-1, a provirally activated mouse
mammary oncogene. Mol. Cell. Biol. 5, 3337–3344.
allahan, D., and Callahan, R. (1987). Mammary tumorigenesis in feral
mice: Identification of a new int locus in mouse mammary tumor
virus (Czech II)-induced mammary tumor virus on mouse chromo-
some 17. J. Virol. 61, 66–74.
erhart, J., and Keller, R. (1986). Region-specific cell activities in am-
phibian gastrulation. Annu. Rev. Cell Biol. 2, 201–229.
inck, L., Nathke, I., Papkoff, J., and Nelson, W. J. (1994a). b-catenin: A
common target for the regulation of cell adhesion by Wnt-1 and Src
signaling pathways. Trends Biochem. Sci. 19, 538–542.
inck, L., Nelson, W. J., and Papkoff, J. (1994b). Wnt-1 modulates
cell–cell adhesion in mammalian cells by stabilizing b-catenin bind-
ing to the cell adhesion protein cadherin. J. Cell. Biol. 124, 729–741.
zant, J. G. (1992). Chimeric antisense RNAs. In “Gene Regulation:
Biology of Antisense RNA and DNA” (R. P. Erickson and J. G. Izant,
Eds.), Raven Press Series on Molecular and Cellular Biology, Vol. 1,
pp. 183–195. Raven Press, New York.
ue, S. F., Bradley, R. S., Rudnicki, J. A., Varmus, H. E., and Brown, A. M.
(1992). The mouse Wnt-1 gene can act via a paracrine mechanism in
transformation of mammary epithelial cells. Mol. Cell. Biol. 12, 321–
328.
lagsbrun, M. (1989). The fibroblast growth factor family: Structural and
biological properties. Prog. Growth Factor Res. 1, 207–235.
nudsen, K. A., and Wheelock, M. J. (1992). Plakoglobin, or an 83-kD
homologue distinct from b-catenin, interacts with E-cadherin and
N-cadherin. J. Cell Biol. 118, 671–679.
i, H., Zhao, W., and Sarkar, N. H. (1994). Dietary regulation of mammary
tumorigenesis in RIII/Sa mice: Investigation of a possible mecha-
nism. Cancer Lett. 79, 199–211.
in, T. P., Guzman, R. C., Osborn, R. C., Thordarson, G., and Nandi, S.
(1992). The role of endocrine, autocrine, and paracrine interactions in
the development of mammary hyperplasia in Wnt-1 transgenic mice.
Cancer Res. 52, 4413–4419.
ong, L., Rubin, R., Baserga, R., and Brodt, P. (1995). Loss of the
metastatic phenotype in murine carcinoma cells expressing an an-
tisense RNA to the insulin-like growth factor receptor. Cancer Res.
55, 1006–1009.
ader, S., and White, J. H. (1993). A steroid-inducible promoter for the
controlled overexpression of cloned genes in eukaryotic cells. Proc.
Natl. Acad. Sci. USA 90, 5603–5607.
M
M
M
M
M
N
N
N
N
N
P
P
P
P
P
P
P
P
R
R
R
R
R
S
S
S
S
S
S
S
S
T
v
V
W
149Wnt-1 ANTISENSE RNA REVERSES MAMMARY TUMOR GROWTHassague, J. (1992). Receptors for the TGF-b family. Cell 69, 1067–1070.
cMahon, A. P. (1992). The Wnt family of developmental regulators.
Trends Genet. 8, 236–242.
cMahon, A. P., and Bradley, A. (1990). The Wnt-1 (int-1) proto-onco-
gene is required for the development of a large region of the mouse
brain. Cell 62, 1073–1085.
cMahon, A. P., and Moon, R. T. (1989). Ectopic expression of the
proto-oncogene int-1 in Xenopus embryos leads to duplication of the
embryonic axis. Cell 58, 1075–1084.
oses, H. L. (1990). TGF-b stimulation and inhibition of cell prolifera-
tion: New mechanistic insights. Cell 63, 245–247.
agafuchi, A., and Takeichi, M. (1988). Cell binding function of E-
cadherin is regulated by the cytoplasmic domain. EMBO J. 7, 3679–
3684.
usse, R. (1997). Cell 89, 321–323.
usse, R., van Ooyen, A., Cox, D., Fung, Y. K. T., and Varmus, H. (1984).
Mode of proviral activation of a putative mammary oncogene (int-1)
on mouse chromosome 15. Nature 307, 131–136.
usse, R., and Varmus, H. E. (1982). Many tumors induced by the
mouse mammary tumor virus contain a provirus integrated in the
same region of the host genome. Cell 31, 99–109.
usse, R., and Varmus, H. E. (1992). Wnt genes. Cell 69, 1073–1087.
apkoff, J., and Aikawa, M. (1998). WNT-1 and HGF regulate GSK3b
activity and b-catenin signalling in mammary epithelial cells. Bio-
chem. Biophys. Res. Commun. 247, 851–858.
apkoff, J., Brown, A. M. C., and Varmus, H. E. (1987). The int-1 proto-
oncogene products are glycoproteins that appear to enter the se-
cretory pathway. Mol. Cell. Biol. 7, 3978–3984.
apkoff, J., Rubinfeld, B., Schryver, B., and Polakis, P. (1996). Wnt-1
regulates free pools of catenins and stabilizes APC–catenin com-
plexes. Mol. Cell. Biol. 16, 2128–2134.
apkoff, J., and Schryver, B. (1990). Secreted int-1 protein is associated
with the cell surface. Mol. Cell. Biol. 10, 2723–2730.
arkin, N. T., Kitajewski, J., and Varmus, H. E. (1993). Activity of Wnt-1 as
a transmembrane protein. Genes Dev. 7, 2181–2193.
eters, G., Brookes, S., Smith, R., and Dickson, C. (1983). Tumorigenesis
by mouse mammary tumor virus: Evidence for a common region for
provirus integration in mammary tumors. Cell 33, 369–377.
iepenhagen, P. A., and Nelson, W. J. (1993). Defining E-cadherin-
associated protein complexes in epithelial cells: Plakoglobin, b-cate-
nin and g-catenin are distinct components. J. Cell Sci. 104, 751–762.
orfiri, E., Rubinfeld, B., Albert, I., Hovanes, K., Waterman, M., and
Polakis, P. (1997). Induction of a b-catenin–LEF-1 complex by Wnt-1
and transforming mutants of b-catenin. Oncogene 15, 2833–2839.
amakrishna, N. R., and Brown, A. M. C. (1993). Wingless, the Drosoph-
ila homolog of the proto-oncogene Wnt-1, can transform mouse
mammary epithelial cells. Development Suppl., 95–103.
esnicoff, M., Sell, C., Rubini, M., Coppola, D., Ambrose, D., Baserga, R.,
and Rubin, R. (1994). Rat glioblastoma cells expressing an antisense
RNA to the insulin-like growth factor-1 (IGF-1) receptor are non-
tumorigenic and induce regression of wild-type tumors. Cancer Res.
54, 2218–2222.
ifkin, D. B., and Moscatelli, D. (1989). Recent developments in the cell
biology of basic fibroblast growth factor. J. Cell Biol. 109, 1–6.ijsewijk, F., van Deemeter, L., Wagenaar, E., Sonnenburg, A., and
Nusse, R. (1987). Transfection of int-1 mammary oncogene in cuboi-
dal RAC mammary cell line results in morphological transformation
and tumorigenicity. EMBO J. 6, 127–131.
ingold, G., Lasfargues, E. Y., Bishop, M., and Varmus (1975). Produc-
tion of mouse mammary tumor virus by cultured cells in the absence
and presence of hormones: Assay by molecular hybridization. Virol-
ogy 65, 35–147.
arkar, N. H. (1995). Clonal variations among multiple primary mam-
mary tumors and within a tumor of individual mice: Insertion muta-
tions of int oncogenes. Virology 212, 490–499.
arkar, N. H., Haga, S., Lehner, A. F., Zhao, W., Imai, S., and Moriwaki,
K. (1994). Insertional mutation of int protooncogenes in the mammary
tumors of a new strain of mice derived from the wild in China:
Normal- and tumor-tissue-specific expression of int-3 transcripts.
Virology 203, 52–62.
arkar, N. H., Pomenti, A. A., and Dion, A. S. (1977). Replication of
mouse mammary tumor virus in tissue culture. I. Establishment of a
mouse mammary tumor cell line, virus characterization and quanti-
tation of virus production. Virology 77, 12–30.
hackleford, G. M., MacArthur, C. A., Kwan, H. C., and Varmus, H. E.
(1993a). Mouse mammary tumor virus infection accelerates mam-
mary carcinogenesis in Wnt-1 transgenic mice by insertional activa-
tion of int-2/Fgf-3 and hst/Fgf-4. Proc. Natl. Acad. Sci. USA 90,
740–744.
hackleford, G. M., Willert, K., Wang, J., and Varmus, H. E. (1993b). The
Wnt-1 proto-oncogene induces changes in morphology, gene expres-
sion, and growth factor responsiveness in PC12 cells. Neuron 11,
865–875.
hapiro, D. N., Jones, B. G., Shapiro, L. H., Dias, P., and Houghton, P. J.
(1994). Antisense-mediated reduction in insulin-like growth factor-1
receptor expression suppresses the malignant phenotype of a hu-
man alveolar rhabdomyosarcoma. J. Clin. Invest. 94, 1235–1242.
outhern, P. J., and Berg, P. (1982). Transformation of mammalian cells
to antibiotic resistance with a bacterial gene under control of the
SV40 early region promoter. J. Mol. Appl. Genet. 1, 327–341.
tein, C. A., and Cheng, Y.-C. (1993). Antisense oligonucleotides as
therapeutic agents—Is the bullet really magical. Science 261, 1004–
1012.
sukamoto, A. S., Grosschedl, R., Guzman, R. C., Parslaow, T., and
Varmus, H. E. (1988). Expression of the int-1 gene in transgenic mice
is associated with mammary gland hyperplasia and adenocarcino-
mas in male and female mice. Cell 55, 619–625.
an der Heyden, M. A. G., Rook, M. B., Hermans, M. M. P., Rijksen, G.,
Boonstra, J., Defize, L. H. K., and Destree, O. H. J. (1998). Identification
of connexin43 as a functional target for Wnt signalling. J. Cell Sci. 111,
1741–1749.
oeller, H. J., Truica, C. I., and Gelmann, E. P. (1998). b-catenin muta-
tions in human prostate cancer. Cancer Res. 58, 2520–2523.
ang, H.-P., Zhang, L., Dandri, M., and Rogler, C. E. (1997). Antisense
downregulation of Nmyc1 in woodchuck hepatoma cells reverses
the malignant phenotype. J. Virol. 72, 2192–2198.
